Blood Advances · 2021 · 20 citations · 10 references
MedicineHematologyOncologyClinical Decision SupportClinical InformaticsGenomic Data AnalysisClinical GenomicsGenomic ProfilingMyelodysplastic SyndromesNext-generation Sequencing In OncologyPhenotype ValidationTumor ClassificationClinical Decision AlgorithmsClinical Decision ModelsClinical Decision RulesClinical Next-generation SequencingClinical Phenotype PredictionCohort ConstructionDiagnostic Prediction ModelsPhenotype Mining
The differential diagnosis of myeloid malignancies is challenging and subject to interobserver variability. We used clinical and next-generation sequencing (NGS) data to develop a machine learning model for the diagnosis of myeloid malignancies independent of bone marrow biopsy data based on a 3-institution, international cohort of patients. The model achieves high performance, with model interpretations indicating that it relies on factors similar to those used by clinicians. In addition, we describe associations between NGS findings and clinically important phenotypes and introduce the use of machine learning algorithms to elucidate clinicogenomic relationships.
10
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal et al. · Blood · 2015 · 1.9K citations · Full text
Medicine, Hematology, Pathology +16